Key points are not available for this paper at this time.
In our hospital-based registry, time of metastatic presentation and disease volume were prognostic for mHSPC pts treated with ADT. This simple prognostic classification system can aid patient counseling and future trial design.
Francini et al. (Sun,) studied this question.